 ATLANTA, Aug. 13, 2021 GLOBE NEWSWIRE -- Alimera Sciences, Inc. Nasdaq: ALIM Alimera, a global pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharmaceuticals for the treatment of retinal diseases, today announced financial results for the second quarter of 2021. Alimera will host a conference call today at 9:00 a.m. EDT to discuss these results. 